מקטובי 15מג ישראל - עברית - Ministry of Health

מקטובי 15מג

medison pharma ltd - binimetinib - טבליות מצופות פילם - binimetinib 15 mg - binimetinib

אוויסל ישראל - עברית - Ministry of Health

אוויסל

omrix biopharmaceuticals ltd, israel - calcium chloride; protein clottable; thrombin - תמיסה - thrombin 800 - 1200 iu / 1 ml; calcium chloride 5.6 - 6.20 mg / 1 ml; protein clottable 50 - 90 mg / 1 ml - combinations - combinations - general haemostasis : evicel is used as supportive treatment in surgery where standard surgical techniques are insufficient, for improvement of haemostasis. efficacy has been demonstrated in liver surgery and orthopaedic surgery.

זמפלר 5 מקגמל תמיסה להזרקה ישראל - עברית - Ministry of Health

זמפלר 5 מקגמל תמיסה להזרקה

abbvie biopharmaceuticals ltd, israel - paricalcitol - תמיסה להזרקה - paricalcitol 5 mcg/ml - paricalcitol - paricalcitol - paricalcitol is indicated for the prevention and treatment of secondary hyperparathyrodism associated with chronic renal failure.

זמפלר 2 מיקרוגרם ישראל - עברית - Ministry of Health

זמפלר 2 מיקרוגרם

abbvie biopharmaceuticals ltd, israel - paricalcitol 2 mcg - capsules - paricalcitol - zemplar is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal insufficiency (chronic kidney disease stage 3 and 4 ) patients and chronic renal failure (chronic kidney disease stage 5) patients on haemodialysis or peritoneal dialysis.

זמפלר 4 מיקרוגרם ישראל - עברית - Ministry of Health

זמפלר 4 מיקרוגרם

abbvie biopharmaceuticals ltd, israel - paricalcitol 4 mcg - capsules - paricalcitol - zemplar is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal insufficiency (chronic kidney disease stage 3 and 4 ) patients and chronic renal failure (chronic kidney disease stage 5) patients on haemodialysis or peritoneal dialysis.

נורויר כמוסות רכות 100 מ"ג ישראל - עברית - Ministry of Health

נורויר כמוסות רכות 100 מ"ג

abbvie biopharmaceuticals ltd, israel - ritonavir 100 mg - capsules - ritonavir - is indicated alone or in combination with other antiretroviral agents for the treatment of patients with hiv infection when therapy is warranted based on clinical and/or immunological evidence of disease progression.

נורויר כמוסות רכות 100 מ"ג ישראל - עברית - Ministry of Health

נורויר כמוסות רכות 100 מ"ג

abbvie biopharmaceuticals ltd, israel - ritonavir 100 mg - capsules - ritonavir - is indicated alone or in combination with other antiretroviral agents for the treatment of patients with hiv infection when therapy is warranted based on clinical and/or immunological evidence of disease progression.

אבוסינאגיס 100 מ"ג ישראל - עברית - Ministry of Health

אבוסינאגיס 100 מ"ג

abbvie biopharmaceuticals ltd, israel - palivizumab 100 mg - powder for solution for injection - palivizumab - is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (rsv). safety and efficacy were established in infants with bronchopulmonary dysplasia (bpd) and in infants with a history of prematurity (35 weeks gestational age) and in children less then 2 years of age,with haemodynamically significant congenital heart disease.

אבוסינאגיס 50 מ"ג ישראל - עברית - Ministry of Health

אבוסינאגיס 50 מ"ג

abbvie biopharmaceuticals ltd, israel - palivizumab 50 mg - powder for solution for injection - palivizumab - is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (rsv). safety and efficacy were established in infants with bronchopulmonary dysplasia (bpd) and in infants with a history of prematurity (35 weeks gestational age) and in children less then 2 years of age,with haemodynamically significant congenital heart disease.

לוקרין פ.ד.ס דפו 3.75 מ"ג ישראל - עברית - Ministry of Health

לוקרין פ.ד.ס דפו 3.75 מ"ג

abbvie biopharmaceuticals ltd, israel - leuprorelin acetate 3.75 mg/vial - suspension for injection - leuprorelin - endometriosis prostatic cancer treatment of uterine fibroids for a period of up to six months. treatment of breast cancer in pre- and peri - menopausal women in whom hormone therapy is specified.